| Bid | 2.05 |
| Market Cap | 55.73M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.68 |
| PE Ratio (ttm) | -3.07 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 2.3 |
| Volume | 53,826 |
| Avg. Volume (20D) | 166,185 |
| Open | 2.07 |
| Previous Close | 2.05 |
| Day's Range | 2.06 - 2.14 |
| 52-Week Range | 1.35 - 3.48 |
| Beta | undefined |
About BEAT
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the...
Analyst Forecast
According to 2 analyst ratings, the average rating for BEAT stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
2 months ago · businesswire.com
HeartBeam Reports Third Quarter 2024 ResultsSANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2024 Results.
2 months ago · businesswire.com
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern TimeSANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time.
